Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Beijing University of Chinese Medicine | OTHER |
| State Administration of Traditional Chinese Medicine of the People's Republic of China | OTHER_GOV |
| China Academy of Chinese Medical Sciences | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe pandemic H1N1 influenza.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Chinese herbal medicines plus western therapy | Experimental |
| |
| western therapy | Active Comparator | including supportive therapy and antivirus therapy when necessary |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Chinese herbal medicines plus western therapy | Drug | injections of Chinese herbal medicines and Chinese herbal medicines decoction& supportive therapy and antivirus therapy when necessary |
| Measure | Description | Time Frame |
|---|---|---|
| incidence of complication | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients. | |
| mortality of pandemic H1N1 influenza and all-cause mortality(only for severe pandemic H1N1 influenza patients) | 28 days | |
| proportion of deteriorating into severe H1N1 influenza (only for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza) | 10 days |
| Measure | Description | Time Frame |
|---|---|---|
| time to allaying a fever | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients | |
| time to symptom relief | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mao Yu | Recruiting | Beijing | Beijing Municipality | 100015 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| western therapy | Drug | supportive therapy and antivirus therapy when necessary |
|
| time and proportion of H1N1 virus turning to negative | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients |
| direct medical cost | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients |
| safety outcome(adverse effects) | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients |
| days in hospital | 10 days for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza;28 days for severe pandemic H1N1 influenza patients |
| dose and usage of hormones(only for severe pandemic H1N1 influenza patients) | 28 days |
| Inflammation of lung tissue(only for severe pandemic H1N1 influenza patients) | 28 days |